MedTrace Logo

Extension of the MIME Robotic System for Stroke Rehabilitation

NCT00995774 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-09-20

Study results available
· View outcomes & findings →

Summary

The goal of this project is to develop and test a new robotic system to accommodate practice of tasks requiring reach, grasp and release of objects. Our previous work has shown that the MIME robot is safe and effective for improving reach in stroke subjects. But adequate control of hand movements is critical to a functional upper limb, and is often resistant to conventional therapeutic interventions. Many stroke survivors have residual ability to flex the fingers, but extension is often limited and impeded by increased passive stiffness in flexors, abnormal levels of increased tone in flexors and weakness in extensors. In a recent study, 38% of stroke survivors reported that impaired hand function was the most disabling motor impairment they faced.

Conditions

  • Stroke
  • Impaired Upper Extremity Function

Interventions

DEVICE

robotic therapy

12 sessions of robot therapy for arm and hand function

OTHER

conventional functional training

12 sessions of conventional therapy for the arm and hand from a physical therapist

DEVICE

robotic therapy

12 sessions of robot therapy for arm and hand function

OTHER

conventional functional training

12 sessions of conventional therapy for the arm and hand from a physical therapist

Sponsors & Collaborators

Principal Investigators

  • Peter S. Lum, PhD · VA Medical Center, DC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00995774 on ClinicalTrials.gov